دورية أكاديمية

Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma

التفاصيل البيبلوغرافية
العنوان: Quality-of-life and performance status results from the phase III RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
المؤلفون: Al-Batran, S.-E. *, Van Cutsem, E., Oh, S.C., Bodoky, G., Shimada, Y., Hironaka, S., Sugimoto, N., Lipatov, O.N., Kim, T.-Y., Cunningham, D., Rougier, P., Muro, K., Liepa, A.M., Chandrawansa, K., Emig, M., Ohtsu, A., Wilke, H.
المصدر: In Annals of Oncology April 2016 27(4):673-679
قاعدة البيانات: ScienceDirect
الوصف
تدمد:09237534
DOI:10.1093/annonc/mdv625